Literature DB >> 22510560

Decreased translation of p21waf1 mRNA causes attenuated p53 signaling in some p53 wild-type tumors.

Li-Ju Chang1, Alan Eastman.   

Abstract

DNA damage induces cell cycle arrest through both Chk1 and the p53 tumor suppressor protein, the latter arresting cells through induction of p21(waf1) protein. Arrest permits cells to repair the damage and recover. The frequent loss of p53 in tumor cells makes them more dependent on Chk1 for arrest and survival. However, some p53 wild type tumor cell lines, such as HCT116 and U2OS, are also sensitive to inhibition of Chk1 due to attenuated p21(waf1) induction upon DNA damage. The purpose of this study is to determine the cause of this attenuated p21(waf1) protein induction. We find that neither the induction of p21(waf1) mRNA nor protein half-life is sufficient to explain the low p21(waf1) protein levels in HCT116 and U2OS cells. The induced mRNA associates with polysomes but little protein is made suggesting these two cell lines have a reduced rate of p21(waf1) mRNA translation. This represents a novel mechanism for disruption of the p53-p21(waf1) pathway as currently known mechanisms involve either mutation of p53 or reduction of p53 protein levels. As a consequence, this attenuated p21(waf1) expression may render some p53 wild type tumors sensitive to a combination of DNA damage plus checkpoint inhibition.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22510560      PMCID: PMC3372393          DOI: 10.4161/cc.20208

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  33 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1.

Authors:  R Melchionna; X B Chen; A Blasina; C H McGowan
Journal:  Nat Cell Biol       Date:  2000-10       Impact factor: 28.824

3.  Preclinical development of the novel Chk1 inhibitor SCH900776 in combination with DNA-damaging agents and antimetabolites.

Authors:  Ryan Montano; Injae Chung; Kristen M Garner; David Parry; Alan Eastman
Journal:  Mol Cancer Ther       Date:  2011-12-27       Impact factor: 6.261

4.  WAF1, a potential mediator of p53 tumor suppression.

Authors:  W S el-Deiry; T Tokino; V E Velculescu; D B Levy; R Parsons; J M Trent; D Lin; W E Mercer; K W Kinzler; B Vogelstein
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

5.  The role of cell cycle progression in cisplatin-induced apoptosis in Chinese hamster ovary cells.

Authors:  C Demarcq; R T Bunch; D Creswell; A Eastman
Journal:  Cell Growth Differ       Date:  1994-09

6.  ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1.

Authors:  H Zhao; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2001-07       Impact factor: 4.272

7.  Abrogation of the S phase DNA damage checkpoint results in S phase progression or premature mitosis depending on the concentration of 7-hydroxystaurosporine and the kinetics of Cdc25C activation.

Authors:  Ethan A Kohn; Nicola D Ruth; Mary Kay Brown; Mark Livingstone; Alan Eastman
Journal:  J Biol Chem       Date:  2002-04-12       Impact factor: 5.157

Review 8.  Decision making by p53: life, death and cancer.

Authors:  M Oren
Journal:  Cell Death Differ       Date:  2003-04       Impact factor: 15.828

9.  p21 is necessary for the p53-mediated G1 arrest in human cancer cells.

Authors:  T Waldman; K W Kinzler; B Vogelstein
Journal:  Cancer Res       Date:  1995-11-15       Impact factor: 12.701

10.  Altered WAF1 genes do not play a role in abnormal cell cycle regulation in breast cancers lacking p53 mutations.

Authors:  K E McKenzie; A Siva; S Maier; I B Runnebaum; R Seshadri; S Sukumar
Journal:  Clin Cancer Res       Date:  1997-09       Impact factor: 12.531

View more
  6 in total

1.  Differential regulation of p21 (waf1) protein half-life by DNA damage and Nutlin-3 in p53 wild-type tumors and its therapeutic implications.

Authors:  Li-Ju Chang; Alan Eastman
Journal:  Cancer Biol Ther       Date:  2012-07-24       Impact factor: 4.742

2.  Human rpL3 induces G₁/S arrest or apoptosis by modulating p21 (waf1/cip1) levels in a p53-independent manner.

Authors:  Annapina Russo; Davide Esposito; Morena Catillo; Concetta Pietropaolo; Elvira Crescenzi; Giulia Russo
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

3.  HIPK1 drives p53 activation to limit colorectal cancer cell growth.

Authors:  Christophe Rey; Isabelle Soubeyran; Isabelle Mahouche; Stephane Pedeboscq; Alban Bessede; François Ichas; Francesca De Giorgi; Lydia Lartigue
Journal:  Cell Cycle       Date:  2013-05-15       Impact factor: 4.534

4.  p53, MDM2, eIF4E and EGFR expression in nasopharyngeal carcinoma and their correlation with clinicopathological characteristics and prognosis: A retrospective study.

Authors:  Peng Zhang; Song-Ke Wu; Ying Wang; Zi-Xuan Fan; Chu-Rong Li; Mei Feng; Peng Xu; Wei-Dong Wang; Jin-Yi Lang
Journal:  Oncol Lett       Date:  2014-10-24       Impact factor: 2.967

5.  The terminal basal mitosis of chicken retinal Lim1 horizontal cells is not sensitive to cisplatin-induced cell cycle arrest.

Authors:  Shahrzad Shirazi Fard; Malin Thyselius; Charlotta All-Ericsson; Finn Hallböök
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

6.  The UbL-UBA Ubiquilin4 protein functions as a tumor suppressor in gastric cancer by p53-dependent and p53-independent regulation of p21.

Authors:  Shengkai Huang; Yan Li; Xinghua Yuan; Mei Zhao; Jia Wang; You Li; Yuan Li; Hong Lin; Qiao Zhang; Wenjie Wang; Dongdong Li; Xin Dong; Lanfen Li; Min Liu; Weiyan Huang; Changzhi Huang
Journal:  Cell Death Differ       Date:  2018-06-13       Impact factor: 15.828

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.